Accenture Life Sciences Blog
Pharmaceutical and medical technology companies face both complexity and opportunity when navigating the current healthcare landscape. Accenture experts will share their insights and opinions on how pharmaceutical and medical technology companies can rethink, reshape and restructure for better patient outcomes during complex times.
 
 
From Accenture Strategy for Life Sciences   Innovation, technology and collaboration—these were the keywords we heard frequently at the 2nd CEO Summit of BioNJ, attended by more than 250 industry professionals in Bridgewater, NJ on October 21, 201...
 
 
 
Published: Oct-24-14
 
The focus on patients and the connected healthcare ecosystem were the main themes in the four days of dedicated Health & Life Sciences breakouts at Salesforce.com’s Dreamforce conference last week in San Francisco.  In a high octane week, head...
 
 
 
 
Last week, Accenture participated in AdvaMed 2014. The event is in its eighth year and is the premier venue for the MedTech industry, with more than 2,300 industry professionals in attendance representing nearly 900 companies and stakeholder group...
 
 
 
 
Growing pressures on healthcare systems around the world combined with increasing consumer expectations have ushered in a new era of digital disruption in today’s healthcare systems. In the United States alone, funding for digital healthcare is pr...
 
 
 
 
While the gap continues to grow between declining pharmaceutical R&D productivity and increasing pharma spending on drug development, it appears the industry agrees on the need to digitize R&D and bring meaningful change to overall R&D...
 
 
 
 
Last week we shared insights from a group of life sciences supply chain executives who attended our recent Accenture Think Tank session during the annual Logipharma Conference. Our group discussed the challenges associated with achieving visibilit...
 
 
 
 
We recently saw the eagerly awaited launch of the Apple Watch and Apple making another strategic move, this time into the healthcare and wearables space. The Apple Watch followed the June launch of Apple’s Health App and Health Kit data cloud, and...
 
 
 
 
It is no surprise that visibility continues to challenge the ongoing transformation of the end-to- end life sciences supply chain. Supply chain executives, together with their IT counterparts, continue to struggle to achieve visibility across the ...
 
 
 
 
In the last decade, scientific advances in the medical environment have allowed us to identify the underlying causes of major diseases with increased understanding—leading the way towards personalized medicine. In this new era, each patient requir...
 
 
 
 
Patient health monitoring via wearable devices is set to revolutionize the life sciences industry over the next few years. According to the Institute for Health Studies, Wearable Technology - Market Assessment, roughly 50 million wearable units w...
 
 
 Next >>
About the Authors
Anne O'Riordan
Anne O'Riordan is Senior Managing Director responsible for Accenture's Global Life Sciences Practice. Worked throughout Europe, the ...
 
Jeffrey Russell
Jeffrey Russell is managing director of Accenture Life Sciences in North America. Russell has more than 20 years of experience worki...
 
Doug Mowen
Doug Mowen is managing director for Accenture’s Medical Technology Practice. With 25 years of experience and 15 years serving the Li...
 
Jeff Elton
Jeff Elton, managing director of Accenture Life Sciences, has broad responsibilities for the strategy and partnerships for ne...
 
Shawn Roman
Shawn Roman is a managing director in Accenture Life Sciences and leads the North America Commercial Services practice. Mr. Roman h...
 
Kevin Julian
Kevin Julian is a managing director and global lead for Accenture's Life Sciences Accelerated R&D Services. Previously he was re...
 
 

 

By using this site you agree that we can place cookies on your device. See our privacy statement for details.